BOSTON--(BUSINESS WIRE)--Jan. 9, 2006--The Endo Pharmaceuticals (NASDAQ:ENDP) Corporate Conference Call took place on 9-Jan-06 5:00pm ET. Management reported that it expects net sales for the year ending 12/31/06 to be approx. $860-880m. ENDP estimates adjusted earnings for the year ending 12/31/06 to be approx. $1.75-1.80 per share, which excludes estimated payments to partners for successful achievement of regulatory milestones and excludes stock compensation charges.
